Parkway Life REIT

Parkway Life REIT ("PLife REIT") is one of Asia's largest listed healthcare REITs. It invests in income-producing real estate and real estate-related assets used primarily for healthcare and healthcare-related purposes. 

See below for the Latest Grab News, Analysis, Profit Results, Share Price Information, and Commentary.

PLife REIT Q1 DPU rises 15.1% on higher SG hospital rents

However, gross revenue fell 2.1% due to yen depreciation and Japan nursing home exits.

DBS’ $72m loan to PLife REIT to finance elder care in Japan

The loan follows the REIT’s Sustainable Finance Framework.

PLife REIT unveils framework to fund green and social projects

Sustainable finance proceeds will go toward projects in Singapore, Japan, and Europe.

PLife REIT profit climbs 10% on Japan and France acquisitions

The higher nursing home income lifted Q3 performance and distributions.

S-REITs a good defensive play on renewed US-China tensions

They have stable cash flows and will benefit from upcoming rate cuts.

Here are the five stocks that may benefit from MAS’ $5b EQDP

Macquarie Equity Research expects the EQDP to be implemented in Q3 2025.

Parkway Life REIT inches up DPU by 1% in FY 2024

 Revenue for the period stood at $145.3m.

Parkway Life REIT raises $180m in oversubscribed private placement

It will use part of the proceeds to fund the acquisition of 11 nursing homes in Europe.

Parkway Life REIT to acquire 11 nursing homes in Europe for $159.9m

The REIT expects to complete the acquisition by Q4 2024.

Parkway Life REIT's NPI falls 2.5% YoY to $68.4m in H1 2024

Despite lower NPI, the REIT declared a 3.5% YoY higher DPU.

Parkway Life REIT’s net property income climbs 14.1% to $139.1m in FY23

With improvement in NPI, the REIT recorded a 2.7% YoY higher DPU.

Parkway Life Reit DPU up 2.8% in YTD 2023

The company's gross revenue recorded 24.6% growth due to higher hospital rents.